L421-2095 Screening compound: 6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H,6H-pyrrolo[2,3-c]pyrazole-5-carboxamide

L421-2095 Screening compound: 6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H,6H-pyrrolo[2,3-c]pyrazole-5-carboxamide
L421-2095 Screening compound: 6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H,6H-pyrrolo[2,3-c]pyrazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L421-2095
6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H,6H-pyrrolo[2,3-c]pyrazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L421-2095

Molecular Formula

C27H33N5OS (C27 H33 N5 OS)

Compound Name

6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H,6H-pyrrolo[2,3-c]pyrazole-5-carboxamide

IUPAC name

6-ethyl-N-[3-(3-methylpiperidin-1-yl)propyl]-1-phenyl-3-(thiophen-2-yl)-1H6H-pyrrolo[23-c]pyrazole-5-carboxamide

SMILES

CCn(c(C(NCCCN1CC(C)CCC1)=O)c1)c2c1c(-c1cccs1)nn2-c1ccccc1

InChI

InChI=1S/C27H33N5OS/c1-3-31-23(26(33)28-14-9-16-30-15-7-10-20(2)19-30)18-22-25(24-13-8-17-34-24)29-32(27(22)31)21-11-5-4-6-12-21/h4-6,8,11-13,17-18,20H,3,7,9-10,14-16,19H2,1-2H3,(H,28,33)/t20-/m0/s1

InChI Key

XLZQYRWKEUYNDB-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27251567

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.66

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.972

Distribution Coefficient, logD

2.400

Water Solubility, LogSw

-4.55

Polar Surface Area

45.223

Acid Dissociation Constant (pKa)

14.74

Base Dissociation Constant (pKb)

9.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

L421-2095 in Drug Discovery

Included in Screening Libraries

SmartTM Library (51161 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L421-2095 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L421-2095?
Check Price and Availability of L421-2095, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L421-2095 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L421-2095
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L421-2095
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L421-2095 available by request